Research Archives - Page 2 of 3 - Rheumatology Advisor

Research

Research Implications of New DEA Ruling on Kratom

A categorization of kratom in Schedule I by the DEA would last for 2 years, with an option to extend it to 3, while the DEA and US Food and Drug Administration examine wh ether kratom has an accepted medical use and decide whether to make the Schedule I categorization permanent.

Next post in Prevention